WHAT IS THE INSPIRE STUDY?

The purpose of this study is to understand whether adding IRX-2 helps delay or prevent oral cancer from coming back after surgery.

IRX-2 will be given in addition to the usual cancer treatment that you and your physician select.

Two-thirds of the people in the INSPIRE study will receive IRX-2, chosen randomly (by chance). The other one-third will not.

© 2017 IRX Therapeutics